A CLINICAL RESEARCH STUDY FOR PATIENTS WITH CHRONIC HEART FAILURE WITH PRESERVED EJECTION FRACTION

A CLINICAL RESEARCH STUDY  FOR PATIENTS WITH CHRONIC HEART FAILURE WITH PRESERVED EJECTION FRACTIONAbout The Clinical Research Studies

Clinical studies add to medical knowledge by allowing researchers to determine whether investigational medications are safe and effective for patients with different medical conditions. These studies are carefully put together and the safety of the studies participants is always the main concern of everyone involved.

The PERSPECTIVE Study

Eligible participants in the PERSPECTIVE clinical research study will take an active drug pill and a placebo pill (contains no active medication). The main purpose of this study is to test the investigational study medication compared to the comparison medication in patients with heart failure with preserved ejection fraction, to see if it has an effect on various mental abilities such as thinking and memory.

Participation in the study will be approximately three years, with visits to see your steady doctor and telephone calls.

Results from this research study are expected to provide information that could help heart failure patients in the future.

The Study Medication

The investigational study medication is being evaluated for use in patients with chronic heart failure with preserved ejection fraction. The comparison medication is a standard of care, approved medication commonly used to treat conditions associated with heart failure. Both medications are tablets taken by mouth.

Participants in this study will be randomly assigned to one of the two medications.

Who Qualifies?

You may be eligible to participate in the
PERSPECTIVE study if you:
• Are 60 years of age or older
• Have been diagnosed with chronic heart failure with preserved ejection fraction
• Have shortness of breath, fatigue or swelling of legs, ankles, or feet

Other requirements apply.

If You Join The Study

If you decide to participate in the PERSPECTIVE study, you sign an informed consent document stating that the details of the study have been explained to you, you understand your responsibilities, and you agree to take part. However, you may withdraw from this study for any reason at anytime.

You will receive the study medication and study-related care at no cost.

Learning More

More information is available at clinicaltrials.gov. The clinical trials.gov identifier for this study is: NCT02884206 (https://clinicaltrials.gov/ct2/show/NCT02884206).

For additional information, or to see if you might qualify for this study, please contact:

Advanced Research for Health Improvement
Call Today! 239-230-2021
1168 Goodlette-Frank Rd. N
Naples, FL 34102
info@arhiusa.com
Hablamos español

Check Also

Managing Anxiety in Breast Cancer Patients through Diet and Exercise

A breast cancer diagnosis can spur many emotions, and anxiety is certainly one of them. …